Roundtable of Basic Neuromodulation Cases

This session will review utilization of neuromodulation to treat a range of chronic pain conditions. Cases will be presented followed by a discussion of each scenario. The session leader will summarize key takeaways from each case. On- and off-label use of neuromodulation devices will be discussed.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Recognize conditions and identify patients who may benefit from treatment with neuromodulation.
  • Describe different approaches to the spine.
  • Explain how different waveforms are used in treating chronic pain.
Read more...
Speaker:

Alon Y. Mogilner, MD PhD

Jolene Smith, DO

Thematic Abstract Presentations

The highest-ranked abstracts have been broken up by topic and selected to present during the following concurrent sessions:

  • Dorsal Root Ganglion Stimulation
  • Brain: Movement Disorders, Psychiatric Disorders and Cognitive Disorders
  • Spinal Cord Stimulation: Waveforms, Energy Delivery and Programming
  • Intrathecal Treatment
  • Basic Science of Neuromodulation: Spinal Cord Stimulation
  • Complications and Safety
Read more...
3:30–5 pm Friday, January 12

Neuroethics in the Grey Zone

This session will focus on two hotly debated and highly relevant topics in neuromodulation: 1) Neuroenhancement and 2) Neuromodulation of Pain.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Discuss the practitioner's responsibility in acknowledging a patient's pain and the ethical impact of treating it.
  • Recognize the moral principles that should govern the decision making process of deciding the proper course of treatment.
  • Explain the lasting effects of endorsing a particular therapy.
Read more...
3:30–5 pm Friday, January 12

NIC: Steps Closer to Human Brain Machine Interfaces

Key tenets in improving neuromodulatory efficacy for existing or novel usage is to delineate how this approach affects cell and network activity and identify optimal stimulation targets and settings. Preclinical studies can aid in these endeavors.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe how brain-machine interface or cortical microstimulation is employed to inform us of neural circuit activity and disease conditions.
  • Identify some of the basic neuroscience techniques used in preclinical studies to unmask novel deep brain stimulation targets for neurological conditions.
  • Explain how alternative deep brain stimulation targets can improve motor function and posture.
Read more...
3:30–5 pm Friday, January 12

Advanced Practice Providers Session

Advanced practice providers (APPs) are an integral part of neuromodulation practices around the world, and it is important for their role to be supported through education in their field, training on application of their skill sets, and gaining insight on how to provide well-rounded care. The APP section of the scientific program aims to provide these tools.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe tools to self-promote and achieve success in the workplace.
  • Identify appropriate billing and coding opportunities for APPs.
  • Discuss ways of integrating cancer pain into practice.
  • Illustrate ways to troubleshoot deep brain stimulation and spinal cord stimulation complications.
Read more...
3:30–5 pm Friday, January 12

Strategies for Practice Development: Residents and Fellows Session

During this interactive session, we will discuss industry partnerships and ancillary revenue streams in a neuromodulation practice. We also will provide insight into how to get involved on a national level to advocate for other neuromodulators and yourself.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify decision points for engaging with new industry partners/technologies, as well as managing relationships with industry in your practice.
  • Describe clinical and ancillary revenue streams in place in practices, including office visits, interventions, pharmacy, durable medical equipment, consulting, research, medicolegal work, and physical therapy.
  • Discuss issues at a national level related to neuromodulation and NANS legislative fellowship experience.
Read more...
3:30–5 pm Friday, January 12

Development of Collaborative Programs Hosted by Neurology Section

In this session, we discuss how neurology and NANS can partner together to improve deep brain stimulation (DBS) outcomes and foster collaboration between DBS neurologists, general neurologists, advanced practice providers, and neurosurgeons.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe effective strategies toward growing a premier DBS program.
  • Discuss partnerships with NANS and industry that aid in growth of DBS as a field.
  • Identify motivators and professional growth targets of DBS neurologists.
Read more...
1:30–3 pm Friday, January 12

American Society of Regional Anesthesia and Pain Medicine (ASRA) Session

This session will review recent clinical guidelines pertaining to periprocedural anticoagulation management and infection risk mitigation, as well as recent advances in neuromodulation for headache treatment.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Discuss best practices for periprocedural anticoagulation management and infection risk mitigation.
  • Describe how existing and emerging neuromodulation therapies can be integrated into the algorithm of headache treatment.
  • Review the top neuromodulation manuscripts published in Regional Anesthesia and Pain Medicine.
Read more...
Subscribe to this RSS feed

Faculty subject to change.